Statement Of Income And Retained Earnings

Astellas Pharma Inc. - Filing #7360307

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
130,639,000,000 JPY
105,929,000,000 JPY
Non-operating income
Non-operating income
216,196,000,000 JPY
165,666,000,000 JPY
Non-operating expenses
Non-operating expenses
8,594,000,000 JPY
1,051,000,000 JPY
Ordinary profit (loss)
338,241,000,000 JPY
270,544,000,000 JPY
Extraordinary income
Extraordinary income
33,758,000,000 JPY
5,150,000,000 JPY
Extraordinary losses
Extraordinary losses
23,876,000,000 JPY
21,561,000,000 JPY
Profit (loss) before income taxes
348,123,000,000 JPY
254,133,000,000 JPY
Income taxes - current
10,719,000,000 JPY
35,204,000,000 JPY
Income taxes - deferred
23,193,000,000 JPY
-6,166,000,000 JPY
Profit (loss)
JPY
JPY
JPY
314,210,000,000 JPY
314,210,000,000 JPY
JPY
JPY
JPY
314,210,000,000 JPY
JPY
314,210,000,000 JPY
JPY
JPY
225,095,000,000 JPY
JPY
JPY
JPY
225,095,000,000 JPY
225,095,000,000 JPY
JPY
JPY
225,095,000,000 JPY
JPY
JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.